BlackRock’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-878,324
| Closed | -$16.1M | – | 5313 |
|
2020
Q4 | $16.1M | Buy |
878,324
+20,990
| +2% | +$386K | ﹤0.01% | 3057 |
|
2020
Q3 | $15.7M | Sell |
857,334
-1,256
| -0.1% | -$23K | ﹤0.01% | 2929 |
|
2020
Q2 | $12.9M | Buy |
858,590
+54,218
| +7% | +$812K | ﹤0.01% | 2986 |
|
2020
Q1 | $12.7M | Sell |
804,372
-5,710
| -0.7% | -$90.3K | ﹤0.01% | 2818 |
|
2019
Q4 | $13.2M | Buy |
810,082
+32,720
| +4% | +$531K | ﹤0.01% | 3071 |
|
2019
Q3 | $11.6M | Buy |
777,362
+27,668
| +4% | +$411K | ﹤0.01% | 3102 |
|
2019
Q2 | $12.4M | Buy |
749,694
+103,540
| +16% | +$1.71M | ﹤0.01% | 3094 |
|
2019
Q1 | $11.2M | Sell |
646,154
-11,844
| -2% | -$205K | ﹤0.01% | 3042 |
|
2018
Q4 | $11.6M | Buy |
657,998
+23,992
| +4% | +$424K | ﹤0.01% | 2994 |
|
2018
Q3 | $11.5M | Buy |
634,006
+45,154
| +8% | +$820K | ﹤0.01% | 3141 |
|
2018
Q2 | $11.5M | Buy |
588,852
+499,237
| +557% | +$9.76M | ﹤0.01% | 3141 |
|
2018
Q1 | $1.57M | Sell |
89,615
-1,717
| -2% | -$30.1K | ﹤0.01% | 3711 |
|
2017
Q4 | $1.03M | Sell |
91,332
-90
| -0.1% | -$1.01K | ﹤0.01% | 3840 |
|
2017
Q3 | $973K | Sell |
91,422
-1,086
| -1% | -$11.6K | ﹤0.01% | 3850 |
|
2017
Q2 | $810K | Sell |
92,508
-511,143
| -85% | -$4.48M | ﹤0.01% | 3845 |
|
2017
Q1 | $7.12M | Buy |
603,651
+601,936
| +35,098% | +$7.1M | ﹤0.01% | 3231 |
|
2016
Q4 | $22K | Sell |
1,715
-109
| -6% | -$1.4K | ﹤0.01% | 3175 |
|
2016
Q3 | $27K | Buy |
1,824
+262
| +17% | +$3.88K | ﹤0.01% | 3153 |
|
2016
Q2 | $19K | Buy |
1,562
+959
| +159% | +$11.7K | ﹤0.01% | 3247 |
|
2016
Q1 | $12K | Buy |
603
+361
| +149% | +$7.18K | ﹤0.01% | 3038 |
|
2015
Q4 | $5K | Hold |
242
| – | – | ﹤0.01% | 3145 |
|
2015
Q3 | $4K | Hold |
242
| – | – | ﹤0.01% | 3072 |
|
2015
Q2 | $9K | Buy |
+242
| New | +$9K | ﹤0.01% | 2842 |
|